Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
CYRX Stock Chart & Stats
$9.32
$0.06(0.70%)
At close: 4:00 PM EST
$9.32
$0.06(0.70%)
Day’s Range― - ―
52-Week Range$4.58 - $10.46
Previous CloseN/A
Volume42.91K
Average Volume (3M)594.50K
Market Cap
$470.63M
Enterprise Value$215.74M
Total Cash (Recent Filing)$425.98M
Total Debt (Recent Filing)$228.52M
Price to Earnings (P/E)6.1
Beta1.31
Next Earnings
Nov 06, 2025EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.05
Shares Outstanding50,066,967
10 Day Avg. Volume452,757
30 Day Avg. Volume594,497
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)0.96
Price to Sales (P/S)1.68
P/FCF Ratio-11.43
Enterprise Value/Market Cap0.46
Enterprise Value/Revenue1.06
Enterprise Value/Gross Profit2.33
Enterprise Value/Ebitda-38.80
Forecast
1Y Price Target
$12.81Price Target Upside37.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Cash PositionRecent sale of CryoPDP to DHL effectively removes a major cash runway overhang on shares, with the company now well capitalized.
FDA ApprovalsThe market for CryoPort Inc is improving, with a growing number of FDA approvals for cell and gene therapy products, which is expected to benefit the company's financial performance.
Revenue GrowthCryoPort Inc reported a strong second quarter with a significant revenue increase from life science and commercially approved products, indicating positive business momentum.
Bears Say
Market CompetitionCryoPort Inc holds a significant market share in clinical trials, with an increasing number of trials supporting its growth potential, but competition in this sector remains intense.
ProfitabilityDespite positive progress, achieving adjusted EBITDA profitability by year-end remains a challenge that could impact investor sentiment.
CryoPort News
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $4.58 and its highest was $10.46 in the past 12 months.
What is CryoPort Inc’s market cap?
CryoPort Inc’s market cap is $470.63M.
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is Nov 06, 2025 which is in 22 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on Aug 05, 2025. The company reported $2.05 earnings per share for the quarter, beating the consensus estimate of -$0.263 by $2.313.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -0.22.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 50,066,967 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of $2.05 in its last earnings report, beating expectations of -$0.263. Following the earnings report the stock price went up 29.822%.
Which hedge fund is a major shareholder of CryoPort Inc?
Currently, no hedge funds are holding shares in CYRX
CryoPort Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.81 (37.45% Upside)
$12.81 (37.45% Upside)
Blogger Sentiment
Bearish
CYRX Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 35.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $123.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.71%
12-Months-Change
Fundamentals
Return on Equity
-8.50%
Trailing 12-Months
Asset Growth
-9.20%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. (CYRX) is a logistics company specializing in temperature-controlled supply chain solutions for the life sciences sector. The company primarily serves the biopharmaceutical, cell and gene therapy, and regenerative medicine industries by providing innovative shipping solutions that ensure the integrity and viability of sensitive biological materials. CryoPort's core products include cryogenic shipping solutions, data monitoring systems, and a range of temperature-controlled packaging options designed to meet the rigorous demands of transporting critical biological samples.
CYRX Company Deck
CYRX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Cryoport's earnings call reflects strong revenue growth and strategic advancements, particularly through the DHL partnership, despite some challenges with a client's therapy pause and regulatory setbacks. The overall business outlook remains positive with continued focus on innovation and global expansion.View all CYRX earnings summariesCYRX Stock 12 Month Forecast
Average Price Target
$12.81
▲(37.45% Upside)
Technical Analysis
Ownership Overview
3.40% Insiders
18.54% Mutual Funds
38.75% Other Institutional Investors
22.11% Public Companies and
Individual Investors